Neoplasms — Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer
Citation(s)
Bade BC, Thomas DD, Scott JB, Silvestri GA Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol. 2015 Jun;10(6):861-71. doi: 10.1097/JTO.0000000000000536. Review. Erratum in: J Thorac Oncol. 2015 Dec;10(12):1712.
Conn VS, Hafdahl AR, Brown SA, Brown LM Meta-analysis of patient education interventions to increase physical activity among chronically ill adults. Patient Educ Couns. 2008 Feb;70(2):157-72. Epub 2007 Nov 26.
Cramp F, Byron-Daniel J Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145. doi: 10.1002/14651858.CD006145.pub3. Review.
Dela Cruz CS, Tanoue LT, Matthay RA Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011 Dec;32(4):605-44. doi: 10.1016/j.ccm.2011.09.001. Review.
Eakin EG, Lawler SP, Winkler EA, Hayes SC A randomized trial of a telephone-delivered exercise intervention for non-urban dwelling women newly diagnosed with breast cancer: exercise for health. Ann Behav Med. 2012 Apr;43(2):229-38. doi: 10.1007/s12160-011-9324-7.
Grustam AS, Severens JL, De Massari D, Buyukkaramikli N, Koymans R, Vrijhoef HJM Cost-Effectiveness Analysis in Telehealth: A Comparison between Home Telemonitoring, Nurse Telephone Support, and Usual Care in Chronic Heart Failure Management. Value Health. 2018 Jul;21(7):772-782. doi: 10.1016/j.jval.2017.11.011. Epub 2018 Mar 21.
Johnsen AT, Petersen MA, Pedersen L, Groenvold M Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med. 2009 Sep;23(6):491-501. doi: 10.1177/0269216309105400. Epub 2009 May 14.
Kanera IM, Willems RA, Bolman CA, Mesters I, Verboon P, Lechner L Long-term effects of a web-based cancer aftercare intervention on moderate physical activity and vegetable consumption among early cancer survivors: a randomized controlled trial. Int J Behav Nutr Phys Act. 2017 Feb 10;14(1):19. doi: 10.1186/s12966-017-0474-2.
Lee IM Physical activity and cancer prevention--data from epidemiologic studies. Med Sci Sports Exerc. 2003 Nov;35(11):1823-7. Review.
McCue M, Fairman A, Pramuka M Enhancing quality of life through telerehabilitation. Phys Med Rehabil Clin N Am. 2010 Feb;21(1):195-205. doi: 10.1016/j.pmr.2009.07.005. Review.
Michaels C The importance of exercise in lung cancer treatment. Transl Lung Cancer Res. 2016 Jun;5(3):235-8. doi: 10.21037/tlcr.2016.03.02. Review.
Siegel R, Ma J, Zou Z, Jemal A Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7. Erratum in: CA Cancer J Clin. 2014 Sep-Oct;64(5):364.
Thompson E, Solà I, Subirana M Non-invasive interventions for improving well-being and quality of life in patients with lung cancer--a systematic review of the evidence. Lung Cancer. 2005 Nov;50(2):163-76. Epub 2005 Aug 31. Review.
Zappa C, Mousa SA Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07. Review.
Monitoring and Telecoaching of Physical Activity in Patients With Stage III and IV Non-small Cell Lung Cancer
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.